Drug development research - JoVE Visualize

Showing results (631-640 of 1,375) with videos related to

Pageof 138

Sort By:

Drug Development Research|March 10, 2026

Ceritinib Induces Mitochondrial Fragmentation in Thyroid Cancer Cells by Targeting Drp-1Dongguang Qin, Wei Ding, Xuesong Wu, et al.

Drug Development Research|June 10, 2026

Harnessing the Ocean's Power: Fucoidan as a Novel Neuroregenerative AgentQingyuan Wu, Xiangqi Hui, Aoyun Cui, et al.

Drug Development Research|April 10, 2026

Ferrocene-Pyrazole Hybrid Induces Ferroptosis and Metabolic Disruption in Pancreatic CancerKuan Liu, Junhao Dai, Jianhua Wei, et al.

Drug Development Research|April 27, 2026

Vitexicarpin Directly Targets RSK2 to Attenuate Migration and Invasion of Triple-Negative Breast Cancer Through Modulating HIF-1α/MMP-9 PathwayShuhui You, Tianhui Wu, Min Qian, et al.

Drug Development Research|April 29, 2026

The Development of Chemical Probes for Targeting Coactivator Associated Arginine Methyltransferase 1 (CARM1) InhibitorsKadalipura P Rakesh, Santosh Kumar Verma, Man Vir Singh, et al.

Drug Development Research|May 26, 2026

Discovery of Novel 5-Substituted-4-Allyl-1,2,4-Triazoles as Potential Nonsteroidal Anti-Inflammatory Agents via Downregulation of iNOS ExpressionSamar H Abbas, Asmaa S A Hammad, Dina M M H El-Kossi, et al.

Drug Development Research|May 26, 2026

Sustainable One-Pot Synthesis of Novel Triazolopyrimidine Derivatives as Selective CDK4 Inhibitors for Breast Cancer TherapyDoaa A Elsayed, Wesam S Shehab, Maysa M Mohamed, et al.

Drug Development Research|May 26, 2026

Santamarine Synergizes With Cisplatin via ROS/JNK Axis to Selectively Induce Apoptosis and DNA Damage in Oral Cancer Cells In VitroHsin-I Lu, Kuan-Liang Chen, Chung-Yi Chen, et al.

Drug Development Research|June 4, 2026

Tramiprosate, the Active Agent of ALZ-801, Modulates Amyloidogenic APP Processing and Tau Phosphorylation in a Cellular Model of Alzheimer's DiseaseKevser Biberoglu, Ozden Tacal

Drug Development Research|June 26, 2023

Design, synthesis, anticancer evaluation, and in silico studies of some thieno[2,3-d]pyrimidine derivatives as EGFR inhibitorsMenna Tallah M Sayed, Peter A Halim, Afaf K El-Ansary, et al.

Pageof 138

Showing results (631-640 of 1,375) with videos related to

Sort By:

Pageof 138

Drug Development Research|March 10, 2026

Ceritinib Induces Mitochondrial Fragmentation in Thyroid Cancer Cells by Targeting Drp-1Dongguang Qin, Wei Ding, Xuesong Wu, et al.

Drug Development Research|June 10, 2026

Harnessing the Ocean's Power: Fucoidan as a Novel Neuroregenerative AgentQingyuan Wu, Xiangqi Hui, Aoyun Cui, et al.

Drug Development Research|April 10, 2026

Ferrocene-Pyrazole Hybrid Induces Ferroptosis and Metabolic Disruption in Pancreatic CancerKuan Liu, Junhao Dai, Jianhua Wei, et al.

Drug Development Research|April 27, 2026

Vitexicarpin Directly Targets RSK2 to Attenuate Migration and Invasion of Triple-Negative Breast Cancer Through Modulating HIF-1α/MMP-9 PathwayShuhui You, Tianhui Wu, Min Qian, et al.

Drug Development Research|April 29, 2026

The Development of Chemical Probes for Targeting Coactivator Associated Arginine Methyltransferase 1 (CARM1) InhibitorsKadalipura P Rakesh, Santosh Kumar Verma, Man Vir Singh, et al.

Drug Development Research|May 26, 2026

Discovery of Novel 5-Substituted-4-Allyl-1,2,4-Triazoles as Potential Nonsteroidal Anti-Inflammatory Agents via Downregulation of iNOS ExpressionSamar H Abbas, Asmaa S A Hammad, Dina M M H El-Kossi, et al.

Drug Development Research|May 26, 2026

Sustainable One-Pot Synthesis of Novel Triazolopyrimidine Derivatives as Selective CDK4 Inhibitors for Breast Cancer TherapyDoaa A Elsayed, Wesam S Shehab, Maysa M Mohamed, et al.

Drug Development Research|May 26, 2026

Santamarine Synergizes With Cisplatin via ROS/JNK Axis to Selectively Induce Apoptosis and DNA Damage in Oral Cancer Cells In VitroHsin-I Lu, Kuan-Liang Chen, Chung-Yi Chen, et al.

Drug Development Research|June 4, 2026

Tramiprosate, the Active Agent of ALZ-801, Modulates Amyloidogenic APP Processing and Tau Phosphorylation in a Cellular Model of Alzheimer's DiseaseKevser Biberoglu, Ozden Tacal

Drug Development Research|June 26, 2023

Design, synthesis, anticancer evaluation, and in silico studies of some thieno[2,3-d]pyrimidine derivatives as EGFR inhibitorsMenna Tallah M Sayed, Peter A Halim, Afaf K El-Ansary, et al.

Pageof 138